Our US Pharmaceuticals portfolio includes key marketed products, many of which are leaders in their respective therapeutic areas. Since 2000, our US division has received the most approvals of any pharmaceutical company in the industry.
Key pharmaceutical products marketed by Novartis in the US are listed below by therapeutic area, brand name and generic name.
Important Information:
Disease categories and product names are listed for your convenience in searching for and finding information about Novartis offerings. They are not intended to provide complete medical or product information. SHOULD YOU HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN MEDICAL DOCTOR OR HEALTHCARE PROVIDER. Please see important safety information in the complete Prescribing Information, available by clicking on highlighted links near product names.
by brand
Afinitor® (everolimus) tablets
Aredia® (pamidronate disodium) for injection
Cataflam® (diclofenac potassium) tablets
Clozaril® (clozapine) tablets
Coartem® (artemether/lumefantrine) tablets
CombiPatch® (estradiol/norethindrone acetate) transdermal system
Comtan® (entacapone) tablets
Desferal® (deferoxamine mesylate) for injection, USP
Diovan HCT® (valsartan and hydrochlorothiazide) combination tablets
patient prescribing information
Diovan® (valsartan) tablets
patient prescribing information
Elidel® (pimecrolimus) cream, 1%
patient prescribing information
Enablex® (darifenacin) tablets
patient prescribing information
Estraderm® (estradiol) transdermal system
patient prescribing information
Exelon® (rivastigmine tartrate) capsules and oral solution
Exelon® Patch (rivastigmine) transdermal system
patient prescribing information
Exforge HCT® (amlodipine, valsartan, hydrochlorothiozide) tablets
patient prescribing information
Exforge® (amlodipine and valsartan) tablets
patient prescribing information
Exjade® (deferasirox) tablets for oral suspension
Extavia® (interferon beta-1b) injection
Famvir® (famciclovir) tablets
Fanapt™ (iloperidone) tablets
Femara® (letrozole) tablets
Focalin® (dexmethylphenidate hydrochloride) tablets
Focalin® XR (dexmethylphenidate hydrochloride) extended-release capsules
Gleevec® (imatinib mesylate) tablets
Ilaris® (canakinumab) subcutaneous injection
patient prescribing information
Lamisil® (terbinafine hydrochloride) tablets
Lamisil® (terbinafine hydrochloride) oral granules
Lescol® (fluvastatin sodium) capsules
Lescol® XL (fluvastatin sodium) extended-release tablets
patient prescribing information
Lopressor HCT® (metoprolol tartrate USP and hydrochlorothiazide USP) tablets
Lopressor® (metoprolol tartrate) tablets and injection, USP
Lotensin HCT® (benazepril hydrochloride and hydrochlorothiazide USP) combination tablets
Lotensin® (benazepril hydrochloride) tablets
Lotrel® (amlodipine besylate and benazepril hydrochloride combination capsule) combination capsules
patient prescribing information
Methergine® (methylergonovine maleate) tablets, USP
Methergine® (methylergonovine maleate) injection, USP
Metopirone® (methylergonovine maleate) capsules
Miacalcin® (calcitonin-salmon) for injection
Miacalcin® (calcitonin-salmon) nasal spray
patient prescribing information
Miochol®-E (acetylcholine chloride) intraocular solution
Myfortic® (mycophenolic acid) delayed-release tablets
Neoral® Oral Solution (cyclosporine) oral solution, USP
Neoral® Soft Gelatin Capsule (cyclosporine) soft gelatin capsule, USP
Parlodel® (bromocriptine mesylate) tablets and capsules
Reclast® (zoledronic acid) Injection
patient prescribing information
Ritalin LA® (methylphenidate hydrochloride) extended-release capsules
Ritalin SR® (methylphenidate hydrochloride) sustained-release tablets, USP
Ritalin® Hydrochloride (methylphenidate hydrochloride) tablets, USP
Sandimmune® Injection (cyclosporine) injection
Sandimmune® Oral Solution (cyclosporine oral solution, USP) oral solution
Sandimmune® Soft Gelatin Capsules (cyclosporine capsules, USP) soft gelatin capsules
Sandostatin LAR® Depot (octreotide acetate) for injectable suspension
Sandostatin® (octreotide acetate) injection
Simulect® (basiliximab) for injection
Stalevo® (carbidopa, levodopa and entacapone) tablets
Starlix® (nateglinide) tablets
Tasigna® (nilotinib) capsules
Tegretol® (carbamazepine) chewable tablets and suspension
Tegretol® -XR (carbamazepine) extended-release tablets
Tekturna® (aliskiren) tablets
patient prescribing information
Tekturna® HCT (aliskiren and hydrochlorothiazide) tablets
patient prescribing information
Tobi® (tobramycin) solution for inhalation
patient prescribing information
Trileptal® (oxcarbazepine) tablets and oral suspension
Tyzeka® (telbivudine) tablets and oral solution
Valturna® (aliskiren and valsartan, USP) tablets
patient prescribing information
Vivelle-Dot® (estradiol) transdermal system
Vivelle® (estradiol) transdermal system
Voltaren® (diclofenac sodium) enteric-coated tablets
Voltaren® -XR (diclofenac sodium) extended-release tablets
Voltaren® Ophthalmic (diclofenac sodium) ophthalmic solution 0.1%
Xolair® (omalizumab) injection
Zometa® (zoledronic acid) for injection
Zortress® (everolimus) tablets
DISEASES & CONDITIONS
Knowing more about different diseases and conditions makes it easier for you to take a more active role in keeping you and your family healthy.
ACCESS TO MEDICINES
Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.
PATIENT ASSISTANCE PROGRAMS
Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.